Cargando…

Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas

BACKGROUND: Differences in parasite transmission intensity influence the process of acquisition of host immunity to Plasmodium falciparum malaria and ultimately, the rate of malaria related morbidity and mortality. Potential vaccines being designed to complement current intervention efforts therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Adu, Bright, Cherif, Mariama K., Bosomprah, Samuel, Diarra, Amidou, Arthur, Fareed K. N., Dickson, Emmanuel K., Corradin, Giampietro, Cavanagh, David R., Theisen, Michael, Sirima, Sodiomon B., Nebie, Issa, Dodoo, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769494/
https://www.ncbi.nlm.nih.gov/pubmed/26921176
http://dx.doi.org/10.1186/s12936-016-1146-4
_version_ 1782418109232054272
author Adu, Bright
Cherif, Mariama K.
Bosomprah, Samuel
Diarra, Amidou
Arthur, Fareed K. N.
Dickson, Emmanuel K.
Corradin, Giampietro
Cavanagh, David R.
Theisen, Michael
Sirima, Sodiomon B.
Nebie, Issa
Dodoo, Daniel
author_facet Adu, Bright
Cherif, Mariama K.
Bosomprah, Samuel
Diarra, Amidou
Arthur, Fareed K. N.
Dickson, Emmanuel K.
Corradin, Giampietro
Cavanagh, David R.
Theisen, Michael
Sirima, Sodiomon B.
Nebie, Issa
Dodoo, Daniel
author_sort Adu, Bright
collection PubMed
description BACKGROUND: Differences in parasite transmission intensity influence the process of acquisition of host immunity to Plasmodium falciparum malaria and ultimately, the rate of malaria related morbidity and mortality. Potential vaccines being designed to complement current intervention efforts therefore need to be evaluated against different malaria endemicity backgrounds. METHODS: The associations between antibody responses to the chimeric merozoite surface protein 1 block 2 hybrid (MSP1 hybrid), glutamate-rich protein region 2 (GLURP R2) and the peptide AS202.11, and the risk of malaria were assessed in children living in malaria hyperendemic (Burkina Faso, n = 354) and hypo-endemic (Ghana, n = 209) areas. Using the same reagent lots and standardized protocols for both study sites, immunoglobulin (Ig) M, IgG and IgG sub-class levels to each antigen were measured by ELISA in plasma from the children (aged 6–72 months). Associations between antibody levels and risk of malaria were assessed using Cox regression models adjusting for covariates. RESULTS: There was a significant association between GLURP R2 IgG3 and reduced risk of malaria after adjusting age of children in both the Burkinabe (hazard ratio 0.82; 95 % CI 0.74–0.91, p < 0.0001) and the Ghanaian (HR 0.48; 95 % CI 0.25–0.91, p = 0.02) cohorts. MSP1 hybrid IgM was associated (HR 0.85; 95 % CI 0.73–0.98, p = 0.02) with reduced risk of malaria in Burkina Faso cohort while IgG against AS202.11 in the Ghanaian children was associated with increased risk of malaria (HR 1.29; 95 % CI 1.01–1.65, p = 0.04). CONCLUSION: These findings support further development of GLURP R2 and MSP1 block 2 hybrid, perhaps as a fusion vaccine antigen targeting malaria blood stage that can be deployed in areas of varying transmission intensity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-016-1146-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4769494
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47694942016-02-28 Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas Adu, Bright Cherif, Mariama K. Bosomprah, Samuel Diarra, Amidou Arthur, Fareed K. N. Dickson, Emmanuel K. Corradin, Giampietro Cavanagh, David R. Theisen, Michael Sirima, Sodiomon B. Nebie, Issa Dodoo, Daniel Malar J Research BACKGROUND: Differences in parasite transmission intensity influence the process of acquisition of host immunity to Plasmodium falciparum malaria and ultimately, the rate of malaria related morbidity and mortality. Potential vaccines being designed to complement current intervention efforts therefore need to be evaluated against different malaria endemicity backgrounds. METHODS: The associations between antibody responses to the chimeric merozoite surface protein 1 block 2 hybrid (MSP1 hybrid), glutamate-rich protein region 2 (GLURP R2) and the peptide AS202.11, and the risk of malaria were assessed in children living in malaria hyperendemic (Burkina Faso, n = 354) and hypo-endemic (Ghana, n = 209) areas. Using the same reagent lots and standardized protocols for both study sites, immunoglobulin (Ig) M, IgG and IgG sub-class levels to each antigen were measured by ELISA in plasma from the children (aged 6–72 months). Associations between antibody levels and risk of malaria were assessed using Cox regression models adjusting for covariates. RESULTS: There was a significant association between GLURP R2 IgG3 and reduced risk of malaria after adjusting age of children in both the Burkinabe (hazard ratio 0.82; 95 % CI 0.74–0.91, p < 0.0001) and the Ghanaian (HR 0.48; 95 % CI 0.25–0.91, p = 0.02) cohorts. MSP1 hybrid IgM was associated (HR 0.85; 95 % CI 0.73–0.98, p = 0.02) with reduced risk of malaria in Burkina Faso cohort while IgG against AS202.11 in the Ghanaian children was associated with increased risk of malaria (HR 1.29; 95 % CI 1.01–1.65, p = 0.04). CONCLUSION: These findings support further development of GLURP R2 and MSP1 block 2 hybrid, perhaps as a fusion vaccine antigen targeting malaria blood stage that can be deployed in areas of varying transmission intensity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-016-1146-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-27 /pmc/articles/PMC4769494/ /pubmed/26921176 http://dx.doi.org/10.1186/s12936-016-1146-4 Text en © Adu et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Adu, Bright
Cherif, Mariama K.
Bosomprah, Samuel
Diarra, Amidou
Arthur, Fareed K. N.
Dickson, Emmanuel K.
Corradin, Giampietro
Cavanagh, David R.
Theisen, Michael
Sirima, Sodiomon B.
Nebie, Issa
Dodoo, Daniel
Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
title Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
title_full Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
title_fullStr Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
title_full_unstemmed Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
title_short Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas
title_sort antibody levels against glurp r2, msp1 block 2 hybrid and as202.11 and the risk of malaria in children living in hyperendemic (burkina faso) and hypo-endemic (ghana) areas
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769494/
https://www.ncbi.nlm.nih.gov/pubmed/26921176
http://dx.doi.org/10.1186/s12936-016-1146-4
work_keys_str_mv AT adubright antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT cherifmariamak antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT bosomprahsamuel antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT diarraamidou antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT arthurfareedkn antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT dicksonemmanuelk antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT corradingiampietro antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT cavanaghdavidr antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT theisenmichael antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT sirimasodiomonb antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT nebieissa antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas
AT dodoodaniel antibodylevelsagainstglurpr2msp1block2hybridandas20211andtheriskofmalariainchildrenlivinginhyperendemicburkinafasoandhypoendemicghanaareas